Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Senti Biosciences (SNTI) EBT Margin (2021 - 2023)

Senti Biosciences (SNTI) has 3 years of EBT Margin data on record, last reported at 5487.09% in Q4 2023.

  • For Q4 2023, EBT Margin rose 3203963.0% year-over-year to 5487.09%; the TTM value through Sep 2024 reached 18746.85%, up 2261617.0%, while the annual FY2023 figure was 4543.12%, 313428.0% down from the prior year.
  • EBT Margin reached 5487.09% in Q4 2023 per SNTI's latest filing, up from 12808.58% in the prior quarter.
  • Across five years, EBT Margin topped out at 5487.09% in Q4 2023 and bottomed at 26552.54% in Q4 2022.
  • Average EBT Margin over 3 years is 3796.51%, with a median of 1064.67% recorded in 2022.
  • Peak YoY movement for EBT Margin: crashed -2617178bps in 2022, then skyrocketed 3203963bps in 2023.
  • A 3-year view of EBT Margin shows it stood at 380.76% in 2021, then crashed by -6874bps to 26552.54% in 2022, then skyrocketed by 121bps to 5487.09% in 2023.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 5487.09% in Q4 2023, 12808.58% in Q3 2023, and 2010.78% in Q2 2023.